Evidence map›Paper›PMID 32816165›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.

Mar Carmona-Abellan, Ivan Martinez-Valbuena, Irene Marcilla, Carla DiCaudo, Isabel Gil, Jorge Nuñez, Maria-Rosario Luquin

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Glial cells in the mammalian olfactory bulb.Frontiers in cellular neuroscience · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Neuropathology changed by 3- and 6-months low-level PMParticle and fibre toxicology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mar Carmona-AbellanHealth Research Institute Biocruces, Barakaldo, Vizcaya, Spain. marcarmonaabellan@gmail.com.ORCID http://orcid.org/0000-0002-3765-1005
Ivan Martinez-ValbuenaCentro de Investigación Médica Aplicada, CIMA, Pamplona, Navarra, Spain.
Irene MarcillaCentro de Investigación Médica Aplicada, CIMA, Pamplona, Navarra, Spain.
Carla DiCaudoCentro Neuromedico, Granada, Spain.
Isabel GilHRI Navarra, IdisNA, Pamplona, Navarra, Spain.
Jorge NuñezClinica Universidad de Navarra, Pamplona, Navarra, Spain.
Maria-Rosario LuquinHRI Navarra, IdisNA, Pamplona, Navarra, Spain.
Navarre Institute of Health Research · ESBioCruces Health research Institute · ESClinica Universidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The olfactory bulb (OB) seems to be the first affected structure in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Lewy body dementia (LBD). Deposits of protein aggregates, increased dopaminergic neurons, and decreased cholinergic inputs have all been described in the OB of these diseases. We investigated here the contribution of the activated microglial cells to the increased deposits of protein aggregates. We quantified the number of activated microglial cells and astrocytes in the OB of patients with histological diagnosis of PD (n = 5), AD (n = 13), and LBD (n = 7) and aged-matched controls (n = 8). Specific consensus diagnostic criteria were applied for AD, LBD, and PD. Protein aggregates were scored in the OB as grade 0, none; grade 1, mild; grade 2, moderate; and grade 3, severe. OB sections from the 33 subjects were stained with specific antibodies markers for reactive astrocytes (GFAP) and microglial cells (Iba1 and HLA-DR). The total number of Iba1-ir (Iba-immunoreactive) and HLAD-DR cells was estimated by stereological analysis, while quantification of astrocytes was performed by GFAP optical density. Statistical analysis was done using the Stata 12.0 software. The number of microglia and activated microglia cells (HLA-RD-ir) was increased in patients with neurodegenerative diseases (p < 0.05). Moreover, the density of GFAP-ir cells was higher in the OB of patients. Neither the number of microglia cells nor the density of astrocytes correlated with the number of b-amyloid and alpha-synuclein deposits, but the density of Iba1-ir cells correlated with the number of p-Tau aggregates. Activated microglial cells and reactive astrocytes are present in the OB of patients with neurodegenerative diseases. The lack of correlation between the number of activated microglia cells and protein deposits indicate that they might independently contribute to the degenerative process. The presence of microglia is related to phosphorylated Tau deposits in neurodegenerative diseases.

Indexed as

Alzheimer DiseaseLewy Body DiseaseMicrogliaNeurodegenerative DiseasesOlfactory BulbAgedalpha-SynucleinHumansalpha-SynucleinAggregatesAstrocytesGlial cellsLewy bodyMicrogliaNeurodegenerationOlfactory bulbParkinson

Identifiers

PMID32816165
OpenAlexW3060471987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.